Traffic light go start restart green light
Pharma

Mirum scores FDA approval for ultra-rare disorder

Rare disease pharma Mirum scored an approval for its ultra-rare bone lesion treatment it bought from Incyte.
Donavyn Coffey Sep 25, 2026 4:10pm
Advancing Treatment A Closer Look at ADT Darolutamide with Dr Rana McKay

Advancing mCSPC Treatment: A Closer Look at ADT + Darolutamide with Dr. Rana McKay

Brought to you by Bayer
showdown clash versus vs crash lightning fight dispute

The Oral GLP-1 Tracker: Scripts bounce back from holiday lull

Sep 25, 2026 2:00pm
Merck Co headquarters

Merck’s Welireg combo nabs FDA nod to expand kidney cancer reach

Sep 25, 2026 11:30am
Lundbeck

Lundbeck relocating US headquarters to Boston in innovation move

Sep 25, 2026 10:41am
Podcast
Drug Pricing

Fierce Pharma Week: Top trends, campaigns and conversations

Sep 25, 2026 9:53am
More News

Lilly-InnoCare, Elevar, China's 5-year plan—Fierce Pharma Asia

Sep 25, 2026 9:38am

Eli Lilly blasted for ‘emotive’ language in GLP-1 press release

Sep 25, 2026 9:01am

Lilly nabs weekly insulin nod from FDA in new challenge to Novo

Sep 25, 2026 8:57am

Former reality star Jenn Fessler on healthcare storytelling

Sep 24, 2026 5:33pm